Critical Review: PolyPid (NASDAQ:PYPD) & Ubiquitech Software (OTCMKTS:UBQU)

Ubiquitech Software (OTCMKTS:UBQU) and PolyPid (NASDAQ:PYPD) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations.

Institutional & Insider Ownership

26.5% of PolyPid shares are held by institutional investors. 24.7% of PolyPid shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Ubiquitech Software and PolyPid”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ubiquitech Software	N/A	N/A	N/A	($0.00)	-0.03
PolyPid	N/A	N/A	-$34.17 million	($1.48)	-3.45

PolyPid is trading at a lower price-to-earnings ratio than Ubiquitech Software, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Ubiquitech Software and PolyPid, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ubiquitech Software	0	0	0	0	0.00
PolyPid	1	0	3	0	2.50

PolyPid has a consensus target price of $11.33, indicating a potential upside of 121.79%. Given PolyPid’s stronger consensus rating and higher probable upside, analysts clearly believe PolyPid is more favorable than Ubiquitech Software.

Profitability

This table compares Ubiquitech Software and PolyPid’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ubiquitech Software	N/A	N/A	N/A
PolyPid	N/A	-311.08%	-150.83%

Summary

PolyPid beats Ubiquitech Software on 5 of the 9 factors compared between the two stocks.

About Ubiquitech Software

Ubiquitech Software Corp. develops Internet marketing and sales software solutions in the United States. The company's Internet sales technologies include Blue Crush Monetization System that creates advertising platforms and improves existing platforms to increase sales; InternationalFortune.com, a lead generation portal for currency trading companies, hedge funds, and other asset managers worldwide; and Blue Crush Connect, a social network that rewards and incentivizes customers. It also operates AffiliateCashExpress.com and NeedFunded.com. Ubiquitech Software Corp. was incorporated in 2007 and is based in Denver, Colorado.

About PolyPid

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.